OR WAIT null SECS
February 20, 2018
A new suite for the encapsulation of highly potent drugs will be added.
November 10, 2017
As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.
November 02, 2017
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
October 17, 2017
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
October 13, 2017
Predicted areas of growth include flow chemistry, fermentation, repatriation of overseas funds, oncology, and API/product integration, but the rate of change is unclear.
October 02, 2017
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
September 26, 2017
Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.
July 18, 2017
Catalent expands the scope of the OptiForm Solution Suite to bridge gap from late-stage discovery to Phase I trials.
July 12, 2017
Pfizer’s new format of ibuprofen (AdvilR Liqui-GelsR Minis) uses Catalent’s softgel technology to deliver the formulation in a more concentrated fill, resulting in smaller capsules.
June 05, 2017
Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.